SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Springview Holdings Ltd. engages in the design and construction of residential and commercial buildings. It involves new construction, reconstruction, alterations, and other general contracting services. The company was founded in 2002 and is headquartered in Singapore.

Springview Holdings Ltd - Ordinary Shares - Class A

Springview Holdings Ltd

Springview Holdings (SPHL) is seeing massive trading interest following announcements of an exclusive global license for Emesyl and a solar-ready homes partnership in Singapore. The stock's ultra-low float has ignited intense community discussion around a potential short squeeze, drawing comparisons to other high-volatility micro-cap runners. Traders are actively navigating reported broker buying restrictions and concerns about potential dilution amidst the rapid surge.

Moolec Science SA engages in the development and production of science-based food ingredients. Its products include pet food, animal feed, and dietary supplements. The company was founded by Gastón Paladini, Henk Hoogenkamp, and Martin Salinas in 2020 and is headquartered in George Town, Cayman Islands.

Moolec Science SA

Moolec Science (MLEC) is trending following a recent reverse stock split that significantly tightened its public float, intensifying speculation around a potential short squeeze. The community is actively discussing its ultra-low share count and recent regulatory approval for its safflower GLASO technology in Argentina, fueling comparisons to other high-volatility low-float plays. Traders are closely monitoring the stock for continued momentum as the company expands its commercialization efforts.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is trending following a significant multi-year defense contract with the Swedish Armed Forces, which bolsters its over $500 million in recent government agreements. This catalyst, combined with ongoing "space sector" enthusiasm and its Google-backed Project Suncatcher, fuels strong bullish sentiment and discussions of potential short squeezes among investors. While many are optimistic about its long-term growth and comparing it favorably to peers, some caution about its rapid ascent.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending on news of its inclusion in the Missile Defense Agency's SHIELD program, often referred to as the 'Golden Dome' initiative, which positions the company for significant defense contracts. This development is fueling widespread community excitement, with many anticipating a short squeeze and highlighting the company's unique direct-to-smartphone satellite technology for both commercial and strategic applications. While some debate the current valuation, bullish sentiment dominates as investors project substantial long-term growth for this space sector innovator.

Regentis Biomaterials Ltd. engages in the development of tissue repair solutions. It focuses on orthopedic treatments through its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue such as inflamed cartilage and bone tissue. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel.

Regentis Biomaterials Ltd.

Regentis Biomaterials

Regentis Biomaterials (RGNT) is trending as a recent IPO with a notably low float, attracting significant attention after securing a new U.S. patent for its GelrinC liquid formulation. The community is actively discussing the potential for a short squeeze due to the tight float and recent news, with many observing strong price action and anticipating further upward momentum as it gains more volume.

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Centene Corp.

Centene (CNC) is a focal point of market discussion as political negotiations around the Affordable Care Act (ACA) subsidies continue to unfold. The community is actively debating whether an extension is imminent, with many anticipating significant upside for the stock given its recent earnings beat and analyst upgrades, while others remain wary of regulatory risks in the managed care sector.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Exxon Mobil is trending due to recent U.S. actions regarding Venezuela and the subsequent intense debate over its vast oil reserves. While some investors foresee a significant long-term opportunity for the energy giant to potentially re-enter the country, others remain cautious, citing the CEO's 'uninvestible' stance given past asset seizures and extensive infrastructure challenges. This polarized outlook is fueling market discussion around XOM's future prospects amidst evolving global oil dynamics.

Tether (USDT) is a cryptocurrency with a value meant to mirror the value of the U.S. dollar. The idea was to create a stable cryptocurrency that can be used like digital dollars. Coins that serve this purpose of being a stable dollar substitute are called “stable coins.” Tether is the most popular stable coin and even acts as a dollar replacement on many popular exchanges! According to their site, Tether converts cash into digital currency, to anchor or “tether” the value of the coin to the price of national currencies like the US dollar, the Euro, and the Yen. Like other cryptos it uses blockchain. Unlike other cryptos, it is [according to the official Tether site] “100% backed by USD” (USD is held in reserve). The primary use of Tether is that it offers some stability to the otherwise volatile crypto space and offers liquidity to exchanges who can’t deal in dollars and with banks (for example to the sometimes controversial but leading exchange Bitfinex).  The digital coins are issued by a company called Tether Limited that is governed by the laws of the British Virgin Islands, according to the legal part of its website. It is incorporated in Hong Kong. It has emerged that Jan Ludovicus van der Velde is the CEO of cryptocurrency exchange Bitfinex, which has been accused of being involved in the price manipulation of bitcoin, as well as tether. Many people trading on exchanges, including Bitfinex, will use tether to buy other cryptocurrencies like bitcoin. Tether Limited argues that using this method to buy virtual currencies allows users to move fiat in and out of an exchange more quickly and cheaply. Also, exchanges typically have rocky relationships with banks, and using Tether is a way to circumvent that.  USDT is fairly simple to use. Once on exchanges like Poloniex or Bittrex, it can be used to purchase Bitcoin and other cryptocurrencies. It can be easily transferred from an exchange to any Omni Layer enabled wallet. Tether has no transaction fees, although external wallets and exchanges may charge one. In order to convert USDT to USD and vise versa through the Tether.to Platform, users must pay a small fee. Buying and selling Tether for Bitcoin can be done through a variety of exchanges like the ones mentioned previously or through the Tether.to platform, which also allows the conversion between USD to and from your bank account.

Tether

Tether is trending due to significant community discussion surrounding its strategic partnership with Rumble, which includes a major acquisition and the integration of crypto payments for creators. While reports highlight Tether's substantial profitability, debates persist regarding its reserve transparency and broader market influence, intensified by recent credit rating assessments. The stablecoin's role in expanding crypto adoption into mainstream platforms and its financial backing are key talking points.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The SPDR S&P Biotech ETF (XBI) is experiencing significant momentum, driven by ongoing M&A speculation within the sector, including reports of a major pharmaceutical company acquiring a clinical-stage oncology firm. Community discussions highlight a broader biotech rebound, with many anticipating sustained strength as large pharmaceutical companies face patent cliffs and look for acquisition targets. This renewed interest is further amplified by the increasing integration of AI in drug discovery, positioning the sector for potential long-term growth.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems (OSS) is trending due to significant anticipation surrounding potential multi-year opportunities, estimated at up to $200 million, in both the defense and datacenter markets. The community is buzzing about OSS as an undervalued "Edge AI" and high-performance computing play, highlighting its strategic positioning for substantial growth following recent contract momentum and a focused shift in its business.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Q4 EPS Estimate for Soleno Therapeutics Increased by Analyst

Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) - Equities researchers at Lifesci Capital lifted their Q4 2025 earnings per share estimates for shares of Soleno Therapeutics in a research...

Soleno Therapeutics (SLNO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

After losing some value lately, a hammer chart pattern has been formed for Soleno Therapeutics (SLNO), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

New Strong Buy Stocks for January 13th

KNOP, OESX, LAND, FET and SLNO have been added to the Zacks Rank #1 (Strong Buy) List on Jan.13, 2026.

SLNO Investors: Contact Kirby McInerney LLP About Investigation into Soleno Therapeutics, Inc.

The law firm of Kirby McInerney LLP continues its investigation on behalf of Soleno Therapeutics, Inc. (Soleno or the Company) (NASDAQ:SLNO) investors concerning the Companys and/or members of its...

Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up - Time to Buy?

Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up - Here's Why...

Soleno Therapeutics (NASDAQ:SLNO) Trading Down 4.2% - What's Next?

Soleno Therapeutics (NASDAQ:SLNO) Trading Down 4.2% - Time to Sell...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics

Soleno Therapeutics leads a rebound in small drug stocks as innovation, pipeline progress and M&A activity fuel optimism for 2026.

5 Small Drug Stocks to Buy as Industry Recovery Picks Up

Innovation is at its peak in the Zacks Medical-Drugs industry. SLNO, NKTR, RIGL, IRWD and MRKR may prove to be good additions to one's portfolio.

Soleno Therapeutics (NASDAQ:SLNO) Upgraded by Zacks Research to "Strong-Buy" Rating

Zacks Research upgraded Soleno Therapeutics from a "hold" rating to a "strong-buy" rating in a report on Monday...

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Soleno Therapeutics Inc

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.64	--	--	N/A
Q3 '25	$0.06	$0.47	717.39%	BEAT
Q2 '25	-$0.45	-$0.09	80.15%	BEAT
Q1 '25	-$0.97	-$0.95	2.06%	BEAT
Q4 '24	-$0.97	-$1.27	-30.42%	MISSED

SLNO
Soleno Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest SLNO News

SLNOSoleno Therapeutics Inc